FOXP3 and cancer: In most cancers, among T cells, VISTA is especially prevalent in FOXP3+ CD4+ Tregs, contributing to promoting their differentiation and maintaining their phenotype while suppressing effector T-cell function (Figure 4B) [26,227,228].